Literature DB >> 7654638

Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study.

A Clarke1, N Black, P Rowe, S Mott, K Howle.   

Abstract

OBJECTIVE: To describe the indications for total abdominal hysterectomy for women with nonmalignant disease and to determine the immediate (initial ten days) and medium term outcome.
DESIGN: A prospective cohort study.
SETTING: Three district general hospitals in shire counties, two in outer London and one London teaching hospital.
SUBJECTS: Three hundred and sixty-six women undergoing total abdominal hysterectomy (with or without other procedures) for nonmalignant disease.
INTERVENTIONS: Self-completed patient questionnaires before and ten days, six weeks and three months after surgery. Data extracted from patients' hospital case notes. MAIN OUTCOME MEASURES: Complications plus change in symptoms, urinary and bowel function, general health status, sexual function, activities of daily living and quality of life.
RESULTS: The principal indications were bleeding, pain or both. Symptoms were severe enough to be socially debilitating and have a major impact on lifestyle. Otherwise, the women were in good health. During the first ten post-operative days the women suffered more pain, urinary discomfort, constipation and a reduction in their ability to perform activities of daily living. Urinary (25%) and wound (25%) infections were the commonest complications. At the same time, significant improvements in psychological health occurred. By six weeks, the principal symptoms had resolved for 95% of the women and early adverse effects on urinary and bowel function had settled. This was reflected in improvements in health status and quality of life including sexual activity. Despite this, these changes did not meet the pre-operative expectations of some women.
CONCLUSIONS: Most women reported substantial benefits from hysterectomy. However, women should be warned about early, transient adverse effects. These findings can serve as a benchmark for nonexperimental evaluations of the effectiveness of new treatment modalities.

Entities:  

Mesh:

Year:  1995        PMID: 7654638     DOI: 10.1111/j.1471-0528.1995.tb11398.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  22 in total

1.  Hysterectomy prevalence by Hispanic ethnicity: evidence from a national survey.

Authors:  Kate M Brett; Jenny A Higgins
Journal:  Am J Public Health       Date:  2003-02       Impact factor: 9.308

2.  Hysterectomy status, estrogen use and quality of life in older women: the Rancho Bernardo study.

Authors:  Donna Kritz-Silverstein; Denise G Von Muhlen; Theodore G Ganiats; Elizabeth Barrett-Connor
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

Review 3.  Menorrhagia.

Authors:  Kirsten Duckitt; Sally Collins
Journal:  BMJ Clin Evid       Date:  2012-01-18

4.  Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2019-09-19

5.  Women's views of two interventions designed to assist in the prophylactic oophorectomy decision: a qualitative pilot evaluation.

Authors:  Vanita Bhavnani; Aileen Clarke; Jack Dowie; Andrew Kennedy; Ian Pell
Journal:  Health Expect       Date:  2002-06       Impact factor: 3.377

Review 6.  Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.

Authors:  Sujoy Ray; Amita Ray
Journal:  Cochrane Database Syst Rev       Date:  2016-11-10

Review 7.  Menorrhagia.

Authors:  Kirsten Duckitt
Journal:  BMJ Clin Evid       Date:  2015-09-18

Review 8.  Menorrhagia.

Authors:  Kirsten Duckitt; Sally Collins
Journal:  BMJ Clin Evid       Date:  2008-09-18

9.  Hysterectomy and urinary incontinence in postmenopausal women.

Authors:  Bela I Kudish; David Shveiky; Robert E Gutman; Vanessa Jacoby; Andrew I Sokol; Rebecca Rodabough; Barabara V Howard; Patricia Blanchette; Cheryl B Iglesia
Journal:  Int Urogynecol J       Date:  2014-06-26       Impact factor: 2.894

10.  The impact of hysterectomy on lower urinary tract symptoms.

Authors:  Daniel Altman; Annika López; Christian Falconer; Jan Zetterström
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.